Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheridan

Showing results (451-460 of 7,542) with videos related to

Pageof 755
Sort By:
Developmental Medicine and Child Neurology|December 1, 1973
The STYCAR panda test for children with severe visual handicapsM D Sheridan
Developmental Medicine and Child Neurology|August 1, 1973
The solo-dot testM D Sheridan
Drugs|November 21, 2024
Seladelpar: First ApprovalSheridan M Hoy
Drugs|July 14, 2024
Mavorixafor: First ApprovalSheridan M Hoy
CNS Drugs|October 17, 2023
Solriamfetol: A Review in Excessive Daytime Sleepiness Associated with Narcolepsy and Obstructive Sleep ApnoeaSheridan M Hoy
Drugs|September 1, 2023
Rozanolixizumab: First ApprovalSheridan M Hoy
Targeted Oncology|February 20, 2016
Dinutuximab: A Review in High-Risk NeuroblastomaSheridan M Hoy
The Journal of Pediatrics|October 16, 2002
Kernicterus parents' groupSusan E Sheridan
Hawaii Medical Journal|September 16, 1999
Risk reduction to prevent sudden infant death syndrome: knowledge and opinions of Hawaii physiciansM S Sheridan
European Journal of Medicinal Chemistry|July 13, 2000
Synthesis and antispasmodic activity of analogues of natural pterosinsSheridan, Frankish, Farrell
Pageof 755

Showing results (451-460 of 7,542) with videos related to

Sort By:
Pageof 755
Developmental Medicine and Child Neurology|December 1, 1973
The STYCAR panda test for children with severe visual handicapsM D Sheridan
Developmental Medicine and Child Neurology|August 1, 1973
The solo-dot testM D Sheridan
Drugs|November 21, 2024
Seladelpar: First ApprovalSheridan M Hoy
Drugs|July 14, 2024
Mavorixafor: First ApprovalSheridan M Hoy
CNS Drugs|October 17, 2023
Solriamfetol: A Review in Excessive Daytime Sleepiness Associated with Narcolepsy and Obstructive Sleep ApnoeaSheridan M Hoy
Drugs|September 1, 2023
Rozanolixizumab: First ApprovalSheridan M Hoy
Targeted Oncology|February 20, 2016
Dinutuximab: A Review in High-Risk NeuroblastomaSheridan M Hoy
The Journal of Pediatrics|October 16, 2002
Kernicterus parents' groupSusan E Sheridan
Hawaii Medical Journal|September 16, 1999
Risk reduction to prevent sudden infant death syndrome: knowledge and opinions of Hawaii physiciansM S Sheridan
European Journal of Medicinal Chemistry|July 13, 2000
Synthesis and antispasmodic activity of analogues of natural pterosinsSheridan, Frankish, Farrell
Pageof 755